Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 2(113), p. 226-231, 2015
DOI: 10.1038/bjc.2015.191
Links
- ORCID
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- ORCID
- [www.rug.nl] | PDF
- [repub.eur.nl] | PDF
- [pure.rug.nl] | PDF
- [dspace.library.uu.nl] | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial
Journal article published in 2015 by
N. Beije,
J. Kraan 
,
W. Taal ,
B. van der Holt ,
Hm M. Oosterkamp,
Am M. Walenkamp,
L. Beerepoot,
M. Hanse,
Me E. van Linde,
A. Otten,
Rm M. Vernhout,
F. Y. F. de Vos,
Jw W. Gratama,
S. Sleijfer,
Mj J. van den Bent
,
W. Taal ,
B. van der Holt ,
Hm M. Oosterkamp,
Am M. Walenkamp,
L. Beerepoot,
M. Hanse,
Me E. van Linde,
A. Otten,
Rm M. Vernhout,
F. Y. F. de Vos,
Jw W. Gratama,
S. Sleijfer,
Mj J. van den Bent
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 